PreventionGenetics
Healthcare Services · Wisconsin, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3800 S Business Park Ave, Marshfield, Wi...Phone Number
(715) 387-0484Website
www.preventiongenetics.comRevenue
$26.7 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
3
5
6
2
About PreventionGenetics
PreventionGenetics, founded in 2004 and headquartered in Marshfield, Wisconsin, is a CLIA and ISO 15189:2012 accredited clinical laboratory specializing in genetic diagnostics. The company provides comprehensive genetic testing services for clinically relevant genes at competitive prices to clients worldwide. PreventionGenetics offers advanced diagnostic solutions including whole genome sequencing (PGnome®) and whole exome sequencing (PGxome®) tests. As a leader in the healthcare diagnostics industry, the company maintains rigorous quality standards while making genetic testing accessible for various medical applications including hereditary disease screening, carrier testing, and personalized medicine.Explore more
PreventionGenetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PreventionGenetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
PreventionGenetics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once PreventionGenetics has new funding data
Click to see if PreventionGenetics had a recent Job posting/layoffs
Earning: See what the market has to say on PreventionGenetics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at PreventionGenetics
Website visits: Recent activity has been detected on your website
Check if PreventionGenetics has recently received funding, and reach out quickly before it becomes old news!
Check out if PreventionGenetics is spiking on competitors!
Product Launch: Get notified when PreventionGenetics launches new products
Recommended Actions
Find VP level buyers at PreventionGenetics
Find 3 more new buyers
Compare Similar Companies to PreventionGenetics
Compare insights from companies similar to PreventionGenetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$65.2M
201-500
Private
-
2015
LC
Lance CooperSenior Director, Lab Operations For Cytogenetics & Microarray
Company Profile Activity
Activity Insights
PreventionGenetics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
PreventionGenetics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about PreventionGenetics.
PreventionGenetics financials insights
Gather financial insights about PreventionGenetics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
PreventionGenetics Tech Stack
A closer look at the technologies used by PreventionGenetics
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Funding
PreventionGenetics has received an SBA PPP loan for $2-5 million from BMO Harris Bank National Association.
Funding
PreventionGenetics News & Media
PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis
MARSHFIELD, Wis.--(BUSINESS WIRE)--PreventionGenetics, a wholly owned subsidiary of Exact Sciences Corp., announced that it is the new administrator of Alnylam Act,® a sponsored genetic testing program by Alnylam Pharmaceuticals, Inc. The program, called Alnylam Act®, provides genetic testing for the diagnosis of acute hepatic porphyria, primary hyperoxaluria type 1 (PH1), and hereditary ATTR (hATTR) amyloidosis. Along with genetic testing, the program includes access to pre and post-test genetExact Sciences Announces Fourth Quarter 2024 Results
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $713 million for the fourth quarter of 2024 and $2.76 billion for the full year of 2024, both ended December 31, 2024. “The Exact Sciences team is off to a good start in 2025, building on the momentum we created in the fourth quarter,” said Kevin Conroy, Chairman and CEO ofExact Sciences Announces Preliminary Fourth Quarter 2024 Results
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 million for the fourth quarter ended December 31, 2024. "The Exact Sciences team delivered strong results to finish 2024, setting us up for sustained growth and profitability in the years to come," said Kevin Conroy, chairman and CEO. "We look forward to expanding our impact as the platformExact Sciences Announces Third-Quarter 2024 Results
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $709 million for the third quarter ended September 30, 2024, compared to $628 million for the same period of 2023. “The Exact Sciences’ team is helping eradicate cancer while strengthening our platform and growing our business efficiently,” said Kevin Conroy, chairman and CEO. “During the third quarter, we deliver
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PreventionGenetics
Sign Up For FreeTo access detailed company insights
PreventionGenetics, founded in 2004 and headquartered in Marshfield, Wisconsin, is a CLIA and ISO 15189:2012 accredited clinical laboratory specializing in genetic diagnostics. The company provides comprehensive genetic testing services for clinically relevant genes at competitive prices to clients worldwide. PreventionGenetics offers advanced diag... Read More
